NYSE: EBS       Emergent Biosolutions
Last Price Today's Change   Day's Range   Trading Volume
57.03   +2.70 (4.97%)  53.35 - 57.83  375,100


Avg Volume (4 weeks):655,576
4 Weeks Range:46.37 - 68.93
4 Weeks Price Volatility (%):
52 Weeks Range:39.11 - 71.19
52 Weeks Price Volatility (%):
Average Price Target: 15.90
Price Target Upside/Downside: -41.13


No recent Headlines for this stock.

Business Background

Emergent BioSolutions Inc is a global biotechnology company that offers biopharmaceutical products to healthcare providers and governments. The company has two operating divisions: biodefense and biosciences. Its specialty biodefense division focuses on countermeasures that address public health threats. The U.S. government is the primary purchaser of these products and often provides substantial funding for their development. Emergent's biosciences business is primarily focused on hematology and oncology therapeutics, with a secondary focus on transplantation, infectious disease, and autoimmunity.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3558  2307  263  2889 

Top 10 Active Counters
 LK 6.40-19.80 
 CCL 7.97-0.83 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 CHK 0.168+0.02 
 SQQQ 20.65-1.30 
 GE 6.90-0.14 
 MRO 3.47+0.35 
 F 4.36-0.04 
 AMD 44.49+0.83 
Partners & Brokers